GLL 398
GLL 398 is a potent and selective oral estrogen receptor degrader, demonstrating an IC50 of 1.14 nM. It effectively inhibits tumor growth in breast cancer xenograft models, supporting its use in both in vitro mechanistic studies and in vivo preclinical research for hormone receptor-positive cancers.
Product Specifications
CAS Number
2077980-80-2
Field of Research
Metabolism Research
Smiles
CC/C (C1=CC=CC=C1) =C (C2=CC=C (B (O) O) C=C2) /C3=CC=C (C=C3) /C=C/C (O) =O
Molecular Formula
C25H23BO4
Molecular Weight
398.26
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
042575-PE 200 µL
TAF11, NT (TAF11, TAF2I, Transcription initiation factor TFIID subunit 11, TFIID subunit p30-beta, Transcription initiation factor TFIID 28kD subunit) (PE) discontinued
Sign In for Pricing
View Details 
MBS6358765-01 0.1 mL
TRNAU1AP, ID (TRNAU1AP, SECP43, TRSPAP1, tRNA selenocysteine 1-associated protein 1, SECp43, tRNA selenocysteine-associated protein 1) (MaxLight 490)
Sign In for Pricing
View Details